5/4/2022 Compass, AstraZeneca move forward in biliary tract cancer treatments 1/14/2022 Surveying VEGF+DLL4 bids: Compass pointed in favorable direction 9/17/2020 Checkpoint Inhibitor CTX-2026 Shows Promising Efficacy in Preclinical Study 8/20/2020 Ayala Pharmaceuticals Announces the Appointment of Vered Bisker-Leib, Ph.D. To … 4/6/2020 Compass Therapeutics’ immuno-oncology prospect clears solid tumors in mice 12/11/2019 Nature Reviews Drug Discovery: Immune agonist antibodies face critical test 12/4/2019 BioWorld -Two’s companies: Crowd in bispecifics still growing as methodology so… 10/2/2018 FierceBiotech’s 2018 Fierce 15 7/13/2018 Compass Therapeutics raises $130 million to develop I-O candidate 7/12/2018 Compass Therapeutics eyes possible IPO after $132M investment